[14C-ETC-1002]
1002-011
Phase 1 small_molecule completed
Quick answer
[14C-ETC-1002] for Hyperlipidemia is a Phase 1 program (small_molecule) at Esperion Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Esperion Therapeutics
- Indication
- Hyperlipidemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed